QVAR (beclomethasone dipropionate HFA) Inhalation Aerosol

Learn about the symptoms and causes of asthma.

Learn why asthma control medication is important, even on days when you're not feeling any symptoms.

Learn how people like you have taken control of their asthma.

Control Your Asthma Symptoms with QVAR®

Asthma may be a chronic persistent condition. That means that, even on days you aren't feeling symptoms, you still need to treat the underlying airway inflammation. If you don't control your asthma, it can lead to more severe symptoms, poor quality of life, and even a greater risk of needing to go to the emergency room.3

QVAR® is an inhaled long-term control medicine for asthma that can help treat persistent asthma. The QVAR® inhaler is designed to give you a consistent dose of medicine.4,5

QVAR® delivers medication to small airways that other medications have trouble reaching.1,2 QVAR can reach the small airways in your lungs because of its small particle size.1,2

References
  1. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002;122:510-516.
  2. Leach CL. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol. 1999;104:S250-S252.
  3. NHLBI Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed April 20, 2010.
  4. Cripps A, Riebe M, Schulze M, Woodhouse R. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Respir Med. 2000;94(suppl B):S3-S9.
  5. Vanden Burgt J, Busse WW, Martin RJ, Szefler SJ, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane beclomethasone extra fine inhalation aerosol) in asthma. J Allergy Clin Immunol. 2000;106:1209-1224.
QVAR® is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age or older. QVAR® is also indicated for asthma patients who require systemic corticosteroid administration, where adding QVAR® may reduce or eliminate the need for systemic corticosteroids.

Important Safety Information


QVAR® does not replace fast-acting (rescue) inhalers for sudden symptoms.

CAUTION: If you are switching from an oral corticosteroid to QVAR®, follow your doctor's instructions to avoid health risks when you stop using oral corticosteroids (See WARNINGS, Prescribing Information).

Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult growth is unknown.

In clinical studies, common side effects included headache and pharyngitis.

Do not stop taking QVAR® abruptly without talking to your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

102997